AI MARKET SCANNING

Vir Biotechnology, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +1.39%
MAX GAP RECORD +32.37%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $VIR
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
+6.47%
May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE)
-4.18%
Feb 23, 2026 Earnings Release 2026-02-23 (AFTER CLOSE)
+32.37%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
-5.00%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
-5.12%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-3.21%
Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE)
+3.80%
Oct 31, 2024 Earnings Release 2024-10-31 (AFTER CLOSE)
-4.67%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.2%
Bullish Gaps (6)
Bearish Gaps (8)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $VIR

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-06 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1345m +23.20%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗